Contact
DMCA
Privacy
Robuta
https://pubmed.ncbi.nlm.nih.gov/40535496/
Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk...
Hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) presents a significant challenge, with recurrence rates ranging from 8% to 20%...
translational medicine
personalized
investigating
ykl
early
https://www.ylojarvenkeilailuliitto.fi/
ykl
ykl